303 related articles for article (PubMed ID: 8973548)
21. Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia.
Larrivée B; Averill DA
Biochem Pharmacol; 1999 Jul; 58(2):291-302. PubMed ID: 10423171
[TBL] [Abstract][Full Text] [Related]
22. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
23. Interaction of P-glycoprotein with a hydrophobic component of rat urine.
Charuk JH; Reithmeier RA
Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959
[TBL] [Abstract][Full Text] [Related]
24. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
25. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein substrates and antagonists cluster into two distinct groups.
Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
[TBL] [Abstract][Full Text] [Related]
27. Identification of the synthetic surfactant nonylphenol ethoxylate: a P-glycoprotein substrate in human urine.
Charuk MH; Grey AA; Reithmeier RA
Am J Physiol; 1998 Jun; 274(6):F1127-39. PubMed ID: 9841506
[TBL] [Abstract][Full Text] [Related]
28. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Borgnia MJ; Eytan GD; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
[TBL] [Abstract][Full Text] [Related]
29. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
30. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
Loo TW; Clarke DM
Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.
Shapiro AB; Fox K; Lam P; Ling V
Eur J Biochem; 1999 Feb; 259(3):841-50. PubMed ID: 10092872
[TBL] [Abstract][Full Text] [Related]
32. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
33. Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.
Qu Q; Chu JW; Sharom FJ
Biochemistry; 2003 Feb; 42(5):1345-53. PubMed ID: 12564938
[TBL] [Abstract][Full Text] [Related]
34. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Shapiro AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):130-7. PubMed ID: 9432000
[TBL] [Abstract][Full Text] [Related]
35. Iodomycin and iodipine, a structural analogue of azidopine, bind to a common domain in hamster P-glycoprotein.
Demmer A; Andreae S; Thole H; Tümmler B
Eur J Biochem; 1999 Sep; 264(3):800-5. PubMed ID: 10491126
[TBL] [Abstract][Full Text] [Related]
36. Characterization and functional reconstitution of the multidrug transporter.
Sharom FJ
J Bioenerg Biomembr; 1995 Feb; 27(1):15-22. PubMed ID: 7629046
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
[TBL] [Abstract][Full Text] [Related]
38. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
39. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein.
Ambudkar SV; Cardarelli CO; Pashinsky I; Stein WD
J Biol Chem; 1997 Aug; 272(34):21160-6. PubMed ID: 9261121
[TBL] [Abstract][Full Text] [Related]
40. Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein.
Eytan GD; Borgnia MJ; Regev R; Assaraf YG
J Biol Chem; 1994 Oct; 269(42):26058-65. PubMed ID: 7523400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
